DETERMINANTS OF SURVIVAL IN ADULT BRAZILIAN AIDS PATIENTS, 1982-1989

被引:53
作者
CHEQUER, P
HEARST, N
HUDES, ES
CASTILHO, E
RUTHERFORD, G
LOURES, L
RODRIGUES, L
机构
[1] UNIV CALIF SAN FRANCISCO,CTR AIDS PREVENT STUDIES,74 NEW MONTGOMERY,SUITE 600,SAN FRANCISCO,CA 94105
[2] MINIST HLTH,NATL FDN HLTH,BRASILIA,BRAZIL
[3] MINIST HLTH,FIOCRUZ FDN,RIO DE JANEIRO,BRAZIL
[4] CALIF STATE DEPT HLTH,BERKELEY,CA 94704
[5] UNIV BRASILIA,BR-70910 BRASILIA,DF,BRAZIL
关键词
AIDS; BRAZIL; HIV; INTRAVENOUS DRUG USE; KAPOSIS SARCOMA; PNEUMOCYSTIS-CARINII; SURVIVAL ANALYSIS; TOXOPLASMOSIS; TUBERCULOSIS;
D O I
10.1097/00002030-199205000-00007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: Little has been published about the length and determinants of survival for persons with AIDS in developing countries. This study examined the survival experience of Brazilian AIDS patients from 1982 to 1989. Design: A retrospective cohort study involving record review of reported AIDS cases. Methods: We obtained information about 2135 adult AIDS patients in Brazil. Local health officials supplied data regarding demographic and clinical characteristics and length of survival. Statistical techniques of survival analysis were applied. Results: Median survival was 5.1 months, much shorter than in developed countries, and there was no improvement in survival for cases diagnosed more recently. Younger patients and those in the intravenous drug use exposure category lived longer than other AIDS patients. Those presenting with Kaposi's sarcoma, esophageal candidiasis, and tuberculosis fared relatively well, while those presenting with multiple diagnoses or toxoplasmosis did more poorly. Conclusions: These results tend to confirm the predictors of AIDS survival previously reported from developed countries and to document the poor survival of AIDS patients in the developing world.
引用
收藏
页码:483 / 487
页数:5
相关论文
共 14 条
  • [1] PREDICTORS OF THE SURVIVAL OF AIDS CASES IN BARCELONA, SPAIN
    BATALLA, J
    GATELL, JM
    CAYLA, JA
    PLASENCIA, A
    JANSA, JM
    PARELLADA, N
    [J]. AIDS, 1989, 3 (06) : 355 - 359
  • [2] FRIEDLAND GH, 1991, J ACQ IMMUN DEF SYND, V4, P144
  • [3] GRECO D, 1988, 4 INT C AIDS STOCKH
  • [4] HARRIS JE, 1990, JAMA-J AM MED ASSOC, V263, P397, DOI 10.1001/jama.263.3.397
  • [5] SURVIVAL TRENDS FOR PATIENTS WITH AIDS
    LEMP, GF
    PAYNE, SF
    NEAL, D
    TEMELSO, T
    RUTHERFORD, GW
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (03): : 402 - 406
  • [6] ZIDOVUDINE AND THE NATURAL-HISTORY OF THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME
    MOORE, RD
    HIDALGO, J
    SUGLAND, BW
    CHAISSON, RE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (20) : 1412 - 1416
  • [7] TRENDS IN SURVIVAL OF DANISH AIDS PATIENTS FROM 1981 TO 1989
    PEDERSEN, C
    GERSTOFT, J
    TAURIS, P
    LUNDGREN, JD
    GOTZSCHE, PC
    BUHL, M
    SALIM, Y
    SCHMIDT, K
    NIELSEN, JO
    [J]. AIDS, 1990, 4 (11) : 1111 - 1116
  • [8] SURVIVAL WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME - EXPERIENCE WITH 5833 CASES IN NEW-YORK-CITY
    ROTHENBERG, R
    WOELFEL, M
    STONEBURNER, R
    MILBERG, J
    PARKER, R
    TRUMAN, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (21) : 1297 - 1302
  • [9] SEAGE GR, 1990, 6 INT C AIDS SAN FRA
  • [10] SIMON R, 1982, CANCER TREAT REP, V66, P37